SAN FRANCISCO--(BUSINESS WIRE)--This is a statement from Clayton Hardman, President and CEO of Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, to clear misunderstandings:
